substance p has been researched along with Bipolar Disorder in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, K; Hidese, S; Ishida, I; Kunugi, H; Matsuo, J; Yoshida, F | 1 |
| Amoruso, A; Bardelli, C; Brunelleschi, S; Cattaneo, CI; Fresu, LG; Manzetti, E | 1 |
| Geyer, MA; Kuczenski, R; Lohr, JB; Niculescu, AB; Ogden, CA; Paulus, MP; Rich, ME; Schork, NJ | 1 |
| Claes, S; Del-Favero, J; Massat, I; Mendlewicz, J; Oswald, P; Souery, D; Van Broeckhoven, C | 1 |
| Adachi, S; Kaiya, H; Moriuchi, I; Namba, M; Tamura, Y; Tanaka, M; Yanaihara, C; Yanaihara, N; Yoshida, H | 1 |
| Berger, M; Fiebich, BL; Lieb, K; Treffurth, Y | 1 |
| Berrettini, WH; Gershon, ES; Nurnberger, JI; Post, RM; Rubinow, DR; Simmons-Alling, S | 1 |
1 review(s) available for substance p and Bipolar Disorder
| Article | Year |
|---|---|
Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?
Topics: Animals; Bipolar Disorder; Humans; Mood Disorders; Neurokinin-1 Receptor Antagonists; Substance P | 2002 |
6 other study(ies) available for substance p and Bipolar Disorder
| Article | Year |
|---|---|
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.
Topics: alpha-MSH; beta-Endorphin; Bipolar Disorder; Depressive Disorder, Major; Humans; Immunoassay; Neurotensin; Oxytocin; Schizophrenia; Substance P | 2023 |
Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study.
Topics: Adult; Bipolar Disorder; Blotting, Western; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Monocytes; NF-kappa B; Pilot Projects; Receptors, Neurokinin-1; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Substance P | 2015 |
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Topics: Animals; Antimanic Agents; Bayes Theorem; Bipolar Disorder; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Gene Expression Profiling; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genomics; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microarray Analysis; Nerve Tissue Proteins; Pharmacogenetics; Phosphoproteins; Protein Precursors; Substance P; Tachykinins; Valproic Acid | 2004 |
Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders.
Topics: Adult; Aged; Alleles; Belgium; Bipolar Disorder; Depressive Disorder, Major; Female; Gene Frequency; Genotype; Haplotypes; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Substance P | 2005 |
Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Chlorpromazine; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Neurotic Disorders; Psychotic Disorders; Schizophrenia; Substance P | 1981 |
CSF substance P immunoreactivity in affective disorders.
Topics: Bipolar Disorder; Chromatography, Gel; Depressive Disorder; Humans; Radioimmunoassay; Substance P | 1985 |